The short version of Epitalon fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2026-02-24. Anything still debated is marked as such rather than presented as settled.
Identity is normally established by reversed-phase high-performance liquid chromatography combined with mass spectrometry, a pairing that separates components and confirms molecular mass at once. Purity is quoted as a percentage from the chromatogram, and figures above ninety-five percent are a frequent commercial specification. Amino acid analysis or sequencing supplies further confirmation when required. Because many short peptides behave similarly under chromatography, retention time alone does not establish sequence; the mass measurement is what separates one tetrapeptide from another, and certificates should report both.
Short peptides such as AEDG are normally supplied as a freeze-dried solid and are kept dry, cold, and shielded from light. Holding at minus twenty degrees Celsius is common for the long term, while a refrigerator suffices for brief periods before use. The material takes up moisture to some degree, so containers should stay sealed and be allowed to reach room temperature before opening, which limits condensation on the contents. Repeated warming and cooling of a single container is discouraged because it admits water and can lower the amount of intact peptide.
The published literature is dominated by a small number of research groups, much of it in Russian-language journals, and independent replication outside those groups is limited. Studies are typically small, use cultured cells or rodent models, and report endpoints that differ between papers, which makes comparison difficult. Large randomised human trials have not appeared in the indexed literature. Questions about absorption, distribution and clearance are therefore still treated as open in reviews that mention the compound.
Epitalon is a synthetic tetrapeptide with the sequence alanine–glutamate–aspartate–glycine, commonly abbreviated AEDG. Its design traces to epithalamin, a peptide fraction prepared from bovine pineal gland extracts that researchers in Saint Petersburg began investigating in the 1970s. The compound has a molecular formula of C14H22N4O9 and a nominal molecular mass near 390 daltons. It holds no approved drug status in the United States or the European Union, and material sold under this name is generally offered as a research chemical rather than a finished pharmaceutical product.
Proposed mechanisms centre on cell-culture observations rather than a defined receptor interaction. Several reports describe increased expression of the telomerase catalytic subunit after exposure of cultured human cells, and the authors attributed the effect to short peptide fragments entering the nucleus and influencing gene transcription. No receptor for the tetrapeptide has been identified, and the free peptide is expected to be degraded rapidly by plasma peptidases. Whether any measurable fraction reaches intact tissues after administration remains an unresolved question rather than an established finding.
| Property | Value | Notes |
|---|---|---|
| Sequence | Ala-Glu-Asp-Gly | Written in three-letter amino acid code |
| Single-letter code | AEDG | Form used in most catalogue entries |
| Typical purity specification | 95 percent or higher | Value read from the HPLC chromatogram |
| Storage, dry solid | Minus 20 degrees Celsius, desiccated | Sealed container, protected from light |
| Handling, solution | Divide into single-use portions | Limits losses from freeze-thaw cycling |
No national medicines regulator has approved epitalon as a therapeutic product. It is generally distributed as a research chemical, and in some jurisdictions selling peptides for human consumption without approval is restricted or prohibited. Certificates of analysis accompanying commercial material vary in which tests are performed, and independent verification of identity and purity is uncommon. Statements about anti-ageing or disease-prevention benefits on vendor pages are marketing claims rather than regulatory findings, a distinction that shapes how the compound is discussed in scientific and popular sources alike.
The most frequently cited laboratory finding is that AEDG increased telomerase activity and extended telomere length in cultured human somatic cells. That work used fetal fibroblast strains and reported changes in enzyme activity alongside altered division counts. Replication by unrelated groups has been limited, and the published record is largely a single-laboratory series rather than a multi-centre programme. The result supports a hypothesis about peptide influence on gene expression in cell culture; it does not by itself establish an effect on telomere length in living animals or in people.
Animal and clinical reports appear mainly in Russian-language journals from the 1990s and 2000s, covering endpoints such as melatonin rhythm, lifespan in aged rodents, and retinal function. Many of these papers involve small groups, lack blinding or placebo comparison, and are difficult to retrieve through indexed databases. Review articles published in English generally summarise the claims without reanalysing the underlying data. Because no large randomised trial exists, the clinical importance of these reported effects stays unresolved and is properly described as an open question.
The peptide is a synthetic analogue of epithalamin, a preparation extracted from bovine pineal glands. Investigators sought a short, chemically defined molecule that would reproduce some of the endocrine and gerontological observations attributed to the glandular extract. Proposed mechanisms centre on induction of telomerase activity, an effect reported in cultured human somatic cells in the early 2000s, together with influences on melatonin secretion and neuroendocrine regulation. Those mechanisms remain incompletely characterised, and the reported telomerase response has not been consistently reproduced by independent groups working in comparable systems.
Published work on this compound consists mainly of in vitro experiments, animal studies, and small clinical investigations, a substantial share of which appeared in Russian-language journals. Sample sizes are generally small, control conditions differ between studies, and several endpoints rely on markers whose clinical meaning is itself debated. Reviews of the longevity field treat the peptide as an early example of telomerase-directed research rather than an established intervention. Regulatory treatment varies by country: some jurisdictions place it under prescription controls, others treat it as a laboratory material, and importation may be restricted regardless of local status.
Epitalon is a synthetic tetrapeptide whose sequence is alanine–glutamate–aspartate–glycine, commonly abbreviated AEDG. It was developed in Russia during the 1980s and 1990s by investigators associated with the St. Petersburg Institute of Bioregulation and Gerontology, who studied short peptides as regulators of gene expression and tissue function. The alternative spelling epithalon appears interchangeably in the literature, and the two names refer to the same molecule. Outside Russia it is encountered chiefly as a research chemical rather than a licensed medicine, and it holds no approval from the United States Food and Drug Administration or the European Medicines Agency.
Material sold for research use varies widely in documented quality. A useful verification package includes a certificate of analysis that states peptide content rather than only net weight, the chromatographic method and column used, and a mass spectrum consistent with the expected mass. Independent testing by a third-party laboratory is occasionally reported. Statements of identity resting only on a supplier label provide little assurance, and the gap between nominal mass and actual peptide content can be substantial once counterions and residual water are counted.
Peptides of this size are generally stable as dry solids but degrade in solution over time. The principal routes are hydrolysis of the peptide backbone and oxidation, with hydrolysis favoured by elevated temperature and extreme pH. Aqueous solutions held at room temperature can show measurable loss of purity within days, while frozen aliquots are considerably more durable. Because the sequence contains neither cysteine nor methionine, oxidation is less of a concern than for many other peptides, but pH control during handling still matters.
A new format concept, A&W Great Food Restaurants, was developed. Ten corporate-owned locations were opened to test the concept: a sit-down, upscale, family-theme restaurant with a large salad bar and homemade ice cream. The first such branch opened in 1978 (1979, according to some sources) at the Lake Forest Shopping Mall in Gaithersburg, Maryland. Emphasis in these restaurants was made on low-calorie foods that covered almost the entirety of the foods found in the fast-food spectrum, except pizza. By 1986, there were plans to have 250 to 300 locations within ten years.
On inhalation and exhalation air moves through the airways in the same direction, thus creating a unidirectional airflow through the lungs. A similar system is found in birds, monitor lizards and iguanas. Most reptiles lack a secondary palate, meaning that they must hold their breath while swallowing. Crocodilians have evolved a bony secondary palate that allows them to continue breathing while remaining submerged (and protect their brains against damage by struggling prey). Skinks (family Scincidae) also have evolved a bony secondary palate, to varying degrees. Snakes took a different approach and extended their trachea instead. Their tracheal extension sticks out like a fleshy straw, and allows these animals to swallow large prey without suffering from asphyxiation.
Bombesin-like peptides comprise a large family of peptides which were initially isolated from amphibian skin, where they stimulate smooth muscle contraction. They were later found to be widely distributed in mammalian neural and endocrine cells. The amphibian peptides which belong to this family are currently classified into three subfamilies; the Bombesin group, which includes bombesin and alytesin; the Ranatensin group, which includes ranatensins, litorin, and Rohdei litorin; and the Phyllolitorin group, which includes Leu(8)- and Phe(8)-phyllolitorins. In mammals and birds two categories of bombesin-like peptides are known, gastrin-releasing peptide (GRP), which stimulates the release of gastrin as well as other gastrointestinal hormones, and neuromedin B (NMB), a neuropeptide whose function is not yet clear. Bombesin-like peptides, like many other active peptides, are synthesized as larger protein precursors that are enzymatically converted to their mature forms. The final peptides are eight to fourteen residues long.
=== Analysis === At one time, coordination compounds were used to identify the presence of metals in a sample. Qualitative inorganic analysis has largely been superseded by instrumental methods of analysis such as atomic absorption spectroscopy (AAS), inductively coupled plasma atomic emission spectroscopy (ICP-AES) and inductively coupled plasma mass spectrometry (ICP-MS).
Platelet basic protein (PBP) is a protein that in humans is encoded by the gene PPBP (previously CXCL7). PBP is a precursor protein that is cleaved into multiple distinct active proteins, notable Connective tissue-activating peptide III (CTAP-III), Beta-thromboglobulin (Beta-TG), Neutrophil-activating peptide 2 (NAP-2), TC-1, and TC-2. PPBP is first translated into the precursor molecule pro-platelet basic protein (PPBP), the first 34 amino acids of which correspond to the signal peptide, while the remaining amino acid residues at positions 35-128 compose PBP. PBP is a protein that is released in large amounts from platelets following their activation. It stimulates various processes including mitogenesis, synthesis of extracellular matrix, glucose metabolism and synthesis of plasminogen activator.
Sources: en.wikipedia.org
Portal 2 development was restarted specifically to keep the portal concept but adding new elements to freshen the gameplay. During this period, Valve had witnessed another student project out of DigiPen, Tag: The Power of Paint, which allows the player to spray paint onto surfaces to alter their behavior. The team was brought into Valve, though not initially as part of the Portal franchise. The Tag team had found a way to incorporate their paints with real-time fluid dynamics code previously made by Valve, and the concept became the "conversion gels" found in Portal 2. Valve included a co-operative play mode, based on their own observations and stories from players about working out the solutions to Portal's puzzles in a group environment. With this feature, they sought the ability to enable cross-platform play of Portal 2 between computers and consoles through Steamworks. This led to a surprise reveal by Newell that Portal 2 would be released on the PlayStation 3, despite previously expressing how he felt about the difficulties in supporting the console, and that it would include support for cross-platform play between the PC and PS3 versions through a limited Steamworks interface. Valve brought in writer Jay Pinkerton, who had formerly worked on National Lampoon, as well as Left 4 Dead writer Chet Faliszek to assist Wolpaw with the larger story.
Climate change in Brazil is causing higher temperatures and longer-lasting heatwaves, changing precipitation patterns, more intense wildfires and heightened fire risk. Brazil's hydropower, agriculture and urban water supplies will be affected. Brazil's rainforests, and the Amazon, are particularly at risk to climate change. At worst, large areas of the Amazon River basin could turn into savannah, with severe consequences for global climate and local livelihoods. Extreme weather events like droughts and flash floods are causing annual losses of around R$13 billion (US$2.6 billion), equivalent to 0.1% of the country's 2022 GDP. Climate impacts could exacerbate poverty. Brazil's greenhouse gas emissions per person are higher than the global average, and Brazil is among the top 10 highest emitting countries. Greenhouse gas emissions by Brazil are over 4% of the annual world total. In 2026 the Brazilian government has launched a National Climate Change Plan which should cut greenhouse gas emissions by 59% - 67% by 2035, and make the country carbon neutral by 2050. Brazil hosted the 2025 United Nations Climate Change Conference, in which it launched the Global carbon market coalition immediately joined by 11 countries including Brazil, China, the European Union, United Kingdom. According to some calculations, a global carbon market can speed up emission reduction seven-fold.
Somalia's network of roads is 22,100 km (13,700 mi) long. As of 2000, 2,608 km (1,621 mi) streets are paved and 19,492 km (12,112 mi) are unpaved. A 750 km (470 mi) highway connects major cities in the northern part of the country, such as Bosaso, Galkayo and Garowe, with towns in the south. Sixty-two airports across Somalia accommodate aerial transportation; seven of these have paved runways. Among the latter, four airports have runways of over 3,047 metres (9,997 ft); two are between 2,438 and 3,047 m (7,999 and 9,997 ft) and one is 1,524 to 2,437 m (5,000 to 7,995 ft) long. There are fifty-five airports with unpaved landing areas. One has a runway of over 3,047 m; four are between 2,438 m and 3,047 m in length; twenty are 1,524 m to 2,437 m; twenty-four are 914 m to 1,523 m; and six are under 914 metres (2,999 ft). Major airports in the nation include the Aden Adde International Airport in Mogadishu, the Hargeisa International Airport in Hargeisa, the Kismayo Airport in Kismayo, the Baidoa Airport in Baidoa, and the Bender Qassim International Airport in Bosaso. Established in 1964, Somali Airlines was the flag carrier of Somalia. It suspended operations during the civil war. However, a reconstituted Somali government later began preparations in 2012 for an expected relaunch of the airline, with the first new Somali Airlines aircraft scheduled for delivery by the end of December 2013. According to the Somali Chamber of Commerce and Industry, the void created by the closure of Somali Airlines has since been filled by various Somali-owned private carriers.
E. × cantabrigiense Stearn, hybrid between E. alpinum and E. pubigerum E. × perralchicum Stearn, hybrid between E. perralderianum and E. pinnatum subsp. colchicum E. × rubrum Morr., hybrid between E. alpinum and E. grandiflorum E. × versicolor Morr., hybrid between E. grandiflorum and E. pinnatum subsp. colchicum E. × warleyense Stearn, hybrid between E. alpinum and E. pinnatum subsp. colchicum E. × youngianum Fisch & C.A.Mey, hybrid between E. diphyllum and E. grandiflorum
=== Glucagon Secretion and Control of Gluconeogenesis === Glucagon functions to signal the liver to begin gluconeogenesis which increases glucose levels in the blood. Glucagon will bind to the glucagon receptors on the plasma membranes of hepatocytes (liver cells). This ligand binding causes the activation of adenylate cyclase, which causes the creation of cyclic AMP (cAMP). As the intracellular concentration of cAMP rises, protein kinase A (PKA) is activated and phosphorylates the transcription factor cAMP Response Element Binding (CREB) protein. CREB then induces transcription of glucose-6-phosphatase and phosphoenolpyruvate carboxylase (PEPCK). These enzymes increase gluconeogenic activity. PKA also phosphorylates phospho-fructokinase 2 (PFK2)/fructose 2,6-biphsophatase (FBPase2), inhibiting PFK2 and activating FBPase2. This inhibition decreases intracellular levels of fructose 2,6-biphosphate and increases intracellular levels of fructose 6-phosphate which decreases glycolytic activity and increases gluconeogenic activity. PKA also phosphorylates pyruvate kinase which causes an increase in intracellular levels of fructose 1,6-biphosphate and decreases intracellular levels of pyruvate, further decreasing glycolytic activity. The most important action of PKA in regulating gluconeogenesis is the phosphorylation of phosphorylase kinase which acts to initiate the glycogenolysis reaction, which is the conversion of glycogen to glucose, by converting glycogen to glucose 1-phosphate. Glucagon is a peptide hormone derived from the proglucagon precursor.
Sources: en.wikipedia.org
Reversed-phase high-performance liquid chromatography is run alongside mass spectrometry. The chromatogram separates components and gives a purity figure, while the mass spectrum confirms that the measured molecular mass matches the expected sequence. Neither measurement on its own is treated as sufficient.
Long-term holding is usually at minus twenty degrees Celsius in a sealed, desiccated container. A refrigerator is adequate for short intervals before use. Light exposure is normally avoided as well. Allowing a cold container to warm before opening reduces moisture condensation on the contents.
Repeated cycles are generally avoided. Each freeze and thaw can promote aggregation or loss of peptide to container surfaces, which reduces the amount available for later work. Dividing a solution into single-use portions at the outset is the usual way to limit this problem.
No. Epithalamin is a heterogeneous peptide fraction obtained from pineal gland extract and contains many components. Epitalon is a single synthetic tetrapeptide with the sequence Ala-Glu-Asp-Gly. Researchers synthesised the shorter peptide while attempting to identify active sequences within the extract.